Company profile
Atlantic International Corp.
NASDAQ: ATLN · Healthcare · Medical - Diagnostics & Research
PublicHQ Billerica, MACIK 0001605888Reports USD
#222 of 1,418 Healthcare companies by revenue39th-percentile growth
EA Score
39DFH 45DQ 22GM 46SS 51
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, workforce scale · ↓ growth stability, Piotroski F
Methodology →Revenue TTM
$583.0M
Rev growth YoY (TTM)
+31.1%
Net income (FY)
-$59.4M
Employees
300
as of 2026-08-19
Market cap
$73.2M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$435.9M$435.9M2025
Net income-$59.4M-$59.4M2025
Operating income-$50.2M-$50.2M2025
Total assets$113.2M$113.2M2025
Liabilities$145.3M$145.3M2025
Equity-$32.1M-$32.1M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY22
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Atlantic International Corp.’s revenue?
Atlantic International Corp. booked $435.9M in FY2025 revenue, contracting 1.5% year over year — slower than 61% of Healthcare companies we track, at a -13.6% net margin.
Peers · Healthcare
Accuray Incorporated68BTarsus Pharmaceuticals, Inc.62CArtivion, Inc.80B+GeneDx Holdings Corp.64CCertara, Inc.68BMiMedx Group, Inc.85AKey facts
CEOJeffrey Jagid
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersBillerica, MA
ExchangeNASDAQ: ATLN
Employees300
IPO date2021-08-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.